Macular Degeneration News and Research

Latest Macular Degeneration News and Research

AI model for detecting ocular disease using retinal images

Researchers present RETFound, a self-supervised learning masked autoencoder-based foundation model for retinal images.

18 Sep 2023

Researchers discover new mechanism in the progression of age-related macular degeneration

Research led by Nicolas Bazan, MD, PhD, Boyd Professor, Ernest C. and Yvette C. Villere Chair for the Study of Retinal Degeneration, and Director of the Neuroscience Center of Excellence at LSU Health New Orleans School of Medicine, suggests that age-related macular degeneration (AMD) decreases an essential fatty acid, preventing the formation of a class of protective molecules and reducing repair potential. The discovery may also open new therapeutic avenues for AMD.

12 Sep 2023

Buck Institute receives $3.5 million federal grant to lead clinical trial of ketone intervention in older adults

The Buck Institute for Research on Aging has received a $3.5 million federal grant to lead the first-ever double-blind, randomized, placebo-controlled clinical trial to understand the effects of ketone ester supplementation on frailty, a condition of vulnerability which develops following age-related decline in multiple physiological systems.

11 Sep 2023

Stem cell patch for treating macular degeneration to enter phase 2b clinical trial

A stem cell patch developed by USC researchers for patients with macular degeneration will soon be tested in a phase 2b clinical trial.

24 Aug 2023

Low-dose atropine eyedrops not effective in slowing myopia progression in children

A study conducted at Vanderbilt University Medical Center and 11 other hospitals and practices across the United States shows that use of low-dose atropine eyedrops, commonly used in a higher dose to treat lazy eye, was no better than a placebo at slowing myopia (nearsightedness) progression and elongation of the eye among children treated for two years.

1 Aug 2023

New technology could revolutionize treatment for age-related macular degeneration

Scientists have found a way to use nanotechnology to create a 3D 'scaffold' to grow cells from the retina –paving the way for potential new ways of treating a common cause of blindness.

28 Jul 2023

MCW professor awarded $13 million NIH grant to study misplaced calcification in AMD and Alzheimer's

Francesca Marassi, PhD, professor and chair of biophysics at the Medical College of Wisconsin (MCW), has been awarded a five-year, $13 million program project grant (PPG) by the National Institutes of Health (NIH) to study misplaced calcification in the eyes and brains of patients suffering from age-related macular degeneration (AMD) and Alzheimer's disease (AD).

18 Jul 2023

Mount Sinai launches first-of-its-kind center for ophthalmic AI

The Icahn School of Medicine at Mount Sinai has launched the Center for Ophthalmic Artificial Intelligence and Human Health, the first of its kind in New York and one of the first in the United States.

5 Jul 2023

Cell therapy using genome-edited iPS cells could be a new treatment for Fabry disease

Induced pluripotent stem (iPS) cells have a great impact on biology and medicine, and they are expected to improve regenerative medicine.

3 Jul 2023

Research finds link between biomarkers in vitreous humor of the eye and Alzheimer's disease

New research from Boston Medical Center found a significant correlation between biomarkers in the vitreous humor of the eye and pathologically confirmed cases of Alzheimer's disease (AD) and Chronic Traumatic Encephalopathy (CTE) in post-mortem brain and eye tissue.

16 Jun 2023

Repeat intraocular corticosteroid injections improve vision in people with persistent or recurrent uveitic macular edema

Repeat treatment with corticosteroid injections improved vision in people with persistent or recurrent uveitis-related macular edema better than two other therapies, according to results from a clinical trial funded by the National Eye Institute.

13 Jun 2023

How innovative technology aids in the fight against diabetes epidemic

Dr Chris Tackaberry, CEO of healthtech AI pioneers Clinithink, highlights the crisis facing the NHS and the importance of Diabetes Week from June 12-18. Every week, diabetes leads to around 180 amputations, 590 heart attacks and 2,300 cases of heart failure. The financial impact of this on the NHS is eye watering.

10 Jun 2023

Study shows Alzheimer’s disease-associated retinopathy can be ameliorated by dietary lysophosphatidylcholine-EPA/DHA

Researchers evaluated the impact of dietary lysophosphatidylcholine (LPC), comprising eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), on retinal function in Alzheimer’s disease (AD)-associated retinopathy.

8 Jun 2023

Groundbreaking study maps molecular architecture of the visual system's integral components

A groundbreaking study has taken a significant step towards understanding the complexities of the human eye.

4 Jun 2023

Eye drops to slow the progression of nearsightedness in kids could be on the horizon

The results of a new clinical trial suggest that the first drug therapy to slow the progression of nearsightedness in kids could be on the horizon.

1 Jun 2023

Technology advance could enable the use of ophthalmologic OCT systems at home

Researchers have shown that a vertical cavity surface emitting laser (VCSEL) diode, which is commonly used in telecommunications and lidar applications, could offer a less expensive light source for swept-source optical coherence tomography (OCT).

1 Jun 2023

Multi-ethnic genome study unlocks new genetic links to health conditions

Research explores the genetic architecture of circulating metabolites, uncovering novel variant-metabolite associations and validating previous findings. It provides insights into the genetic contribution to metabolite levels and potential implications for human disease.

31 May 2023

Researchers use AI models to advance drug delivery system for chronic eye diseases

Wilmer Eye Institute, Johns Hopkins Medicine researchers say they have used artificial intelligence models and machine-learning algorithms to successfully predict which components of amino acids that make up therapeutic proteins are most likely to safely deliver therapeutic drugs to animal eye cells.

24 May 2023

New small-molecule drugs show potential clinical utility in treating world’s leading causes of blindness

In a University of California, Irvine-led study, researchers have discovered small-molecule drugs with potential clinical utility in the treatment of age-related macular degeneration (AMD), diabetic retinopathy (DR), and retinitis pigmentosa (RP).

9 May 2023

Scientists secure funding for cutting-edge research on age-related macular degeneration

A team of scientists led by a Northumbria University academic has won funding to research an eye disease suffered by over 190 million people worldwide.

5 Apr 2023

Macular Degeneration News and Research

Latest Macular Degeneration News and Research

AI model for detecting ocular disease using retinal images

Researchers discover new mechanism in the progression of age-related macular degeneration

Buck Institute receives $3.5 million federal grant to lead clinical trial of ketone intervention in older adults

Stem cell patch for treating macular degeneration to enter phase 2b clinical trial

Low-dose atropine eyedrops not effective in slowing myopia progression in children

New technology could revolutionize treatment for age-related macular degeneration

MCW professor awarded $13 million NIH grant to study misplaced calcification in AMD and Alzheimer's

Mount Sinai launches first-of-its-kind center for ophthalmic AI

Cell therapy using genome-edited iPS cells could be a new treatment for Fabry disease

Research finds link between biomarkers in vitreous humor of the eye and Alzheimer's disease

Repeat intraocular corticosteroid injections improve vision in people with persistent or recurrent uveitic macular edema

How innovative technology aids in the fight against diabetes epidemic

Study shows Alzheimer’s disease-associated retinopathy can be ameliorated by dietary lysophosphatidylcholine-EPA/DHA

Groundbreaking study maps molecular architecture of the visual system's integral components

Eye drops to slow the progression of nearsightedness in kids could be on the horizon

Technology advance could enable the use of ophthalmologic OCT systems at home

Multi-ethnic genome study unlocks new genetic links to health conditions

Researchers use AI models to advance drug delivery system for chronic eye diseases

New small-molecule drugs show potential clinical utility in treating world’s leading causes of blindness

Scientists secure funding for cutting-edge research on age-related macular degeneration

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Macular Degeneration News and Research

Latest Macular Degeneration News and Research

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Newsletters you may be interested in